Rhythm Biosciences to Raise AU$3.8 Million via Share Placement; Shares Rise 5%
MT Newswires Live
Aug 18
Rhythm Biosciences (ASX:RHY) received firm commitments to raise AU$3.8 million through a placement of 41.7 million new shares at AU$0.09 apiece to existing and new institutional, professional, and sophisticated investors, according to a Monday filing with the Australian bourse.
The offer price is a nearly 25% discount to the stock's 15-day volume-weighted average price, the filing said.
Proceeds will be used for research and development activities, commercialization of products, and working capital, the filing added.
Shares of the company rose nearly 5% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.